Related Experiment Videos
Colorectal cancer with and without microsatellite instability involves different genes.
S Salahshor1, U Kressner, L Pâhlman
1Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden.
Genes, Chromosomes & Cancer
|September 29, 1999
Summary
Colorectal cancer develops through distinct genetic pathways. Microsatellite instability (MSI)-positive tumors frequently involve TGFbetaR2 mutations, unlike MSI-negative tumors which often have APC and TP53 alterations.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) tumorigenesis is a multistep genetic process.
- Familial adenomatosis polyposis (FAP) involves APC gene mutations, a commonality also seen in sporadic CRC.
- Hereditary nonpolyposis colorectal cancer (HNPCC) is linked to DNA mismatch repair gene mutations, leading to microsatellite instability (MSI).
Purpose of the Study:
- To investigate distinct genetic pathways in MSI-positive versus MSI-negative sporadic colorectal cancers.
- To compare the prevalence of mutations in APC, KRAS, TP53, and TGFbetaR2 genes between these two groups.
- To explore the role of beta-catenin mutations in MSI-positive CRC.
Main Methods:
- Analysis of 191 sporadic colorectal cancer samples.
- Genotyping for mutations in APC, KRAS, TP53, and TGFbetaR2 genes.
- Screening for beta-catenin mutations in MSI-positive tumors.
Main Results:
- MSI-positive tumors showed a high prevalence of TGFbetaR2 mutations (86%) compared to MSI-negative tumors (0.6%).
- A significant negative association was observed between MSI and alterations in APC and TP53 genes.
- No beta-catenin mutations were found in MSI-positive tumors.
- KRAS mutation rates were lower in MSI-positive tumors, though not statistically significant.
Conclusions:
- Colorectal cancer carcinogenesis differs between MSI-positive and MSI-negative tumors.
- MSI-positive CRC likely follows a distinct pathway involving TGFbetaR2, while MSI-negative CRC is associated with APC and TP53 alterations.
- These findings highlight the heterogeneity of colorectal cancer development.